Acutus Medical (AFIB)
(Delayed Data from OTC)
$0.03 USD
-0.01 (-20.21%)
Updated Jul 15, 2024 02:54 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AFIB 0.03 -0.01(-20.21%)
Will AFIB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AFIB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AFIB
Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates
USANA Health Sciences (USNA) Tops Q2 Earnings and Revenue Estimates
AFIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates
Lyell Immunopharma (LYEL) Reports Q3 Loss, Lags Revenue Estimates
Other News for AFIB
Acutus Medical GAAP EPS of -$0.06, revenue of $3.6M
Acutus Medical Reports First Quarter 2024 Financial Results
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Tuesday's Intraday Session